cflagospharma Profile Banner
Carlos F. Lagos Profile
Carlos F. Lagos

@cflagospharma

Followers
578
Following
2K
Media
66
Statuses
2K

Pharmaceutical Chemist, Molecular Craftsman, PhD

Santiago-Chile
Joined March 2010
Don't wanna be here? Send us removal request.
@cflagospharma
Carlos F. Lagos
1 month
RT @MushtaqBilalPhD: Libgen, Sci-Hub, and Z-library had millions of pirated academic books and papers. So, they were shut down. We shouldn….
0
240
0
@cflagospharma
Carlos F. Lagos
4 months
RT @wpwalters: New Practical Cheminformatics Post, "Useful RDKit Utils - A Mötley Collection of Helpful Routines".h….
0
10
0
@cflagospharma
Carlos F. Lagos
5 months
RT @NatRevDrugDisc: For readers interested in siRNA therapies, here's a review https://t.co….
0
36
0
@cflagospharma
Carlos F. Lagos
5 months
RT @CarlssonLab: Identifying ligands for therapeutic targets among billions of compounds is challenging! Can we search ultra-large chemic….
Tweet card summary image
nature.com
Nature Computational Science - Combining conformal prediction machine learning with molecular docking, a method to efficiently screen multi-billion-scale libraries is developed, enabling the...
0
21
0
@cflagospharma
Carlos F. Lagos
6 months
RT @NatRevDrugDisc: For readers interested in RNA-based medicines such as antisense oligonucleotides and siRNAs, here's a review discussing….
0
64
0
@cflagospharma
Carlos F. Lagos
6 months
RT @pelaofunk: Solo falta el 10%. muy muy cerca de la meta!!! .Aun puedes ADQUIRIR TU ENTRADA PARA MAÑANA O HACER TU DONACIÓN. https://t….
0
3
0
@cflagospharma
Carlos F. Lagos
6 months
RT @gmrepetto: El último día de febrero se conmemora el día mundial de las #EnfermedadesRaras #PocoFrecuentes @rarediseaseday . En preparac….
0
10
0
@cflagospharma
Carlos F. Lagos
6 months
RT @NatRevDrugDisc: For readers interested in personalized therapeutics such as antisense oligonucleotides for ultra-rare diseases, this re….
0
19
0
@cflagospharma
Carlos F. Lagos
6 months
RT @NatRevDrugDisc: For readers interested in cancer immunotherapy, this Review in our February issue discusses opportunties and challenges….
0
43
0
@cflagospharma
Carlos F. Lagos
6 months
RT @NatRevDrugDisc: For readers interested in therapeutic strategies for Duchenne muscular dystrophy, here's a review..
0
33
0
@cflagospharma
Carlos F. Lagos
6 months
RT @NatRevDrugDisc: For readers interested in new epilepsy therapies in development, here's a comprehensive recent review ..
0
48
0
@cflagospharma
Carlos F. Lagos
6 months
RT @MushtaqBilalPhD: Google just introduced an AI co-scientist. "To help uncover new, original knowledge and to formulate. novel research….
0
99
0
@cflagospharma
Carlos F. Lagos
6 months
RT @aipulserx: How do AI-powered protein-ligand docking methods compare to traditional physics-based approaches in terms of accuracy, physi….
0
4
0
@cflagospharma
Carlos F. Lagos
6 months
RT @VRID_USS: 🎓Nos enorgullece felicitar a nuestros y nuestras estudiantes de doctorado @USanSebastian por haber logrado la adjudicación de….
0
3
0
@cflagospharma
Carlos F. Lagos
7 months
RT @NatRevDrugDisc: For readers interested in extracellular targeted protein degradation, here's a comprehensive review of the various stra….
0
46
0
@cflagospharma
Carlos F. Lagos
7 months
RT @swapnakpanda: "Foundations of Machine Learning". A 505-pages book from MIT for beginners is 💯 FREE.
Tweet media one
0
631
0
@cflagospharma
Carlos F. Lagos
7 months
RT @NatureBiotech: A human metabolic map of pharmacological perturbations reveals drug modes of action https://t.co….
0
83
0